Open AccessEvinacumab — an ANGPTL3 inhibitor; a new drug in the treatment of lipid disorders. Review on the literature and clinical studies
Author(s) -
Stanisław Surma,
Monika Romańczyk,
Krzysztof J. Filipiak
Publication year - 2021
Publication title -
folia cardiologica
Language(s) - English
Resource type - Journals
eISSN - 2353-7760
pISSN - 2353-7752
DOI - 10.5603/fc.2021.0005
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , endocrinology , drug , lipid metabolism , obesity , clinical trial , disease , metabolic syndrome , pharmacology